Inventive step, Patents, Pharma, Pharmaceutical patent, Priority right, Spain, Sufficiency of disclosure, Validity

(Clifford Chance)/ /2 Comments

This morning, the Barcelona Appeal Court has announced a judgment of 18 July 2024, reversing the judgment of 15 January 2024 from Commercial Court number 4 of Barcelona, which had found patent EP 1,427,415 (“EP ‘415”), protecting apixaban, to be invalid. The main highlights of the decision may be summarized as follows: The first interesting…

European Union, Patents, TRIPS, TRIPs Agreement

(Clifford Chance)/

As most readers will be well aware, one of the hottest topics in the patent world is the broadening of the Bolar provision envisaged in the Proposal for a Directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive…

EPO, EPO Decision, Plausibility

(Clifford Chance)/ /6 Comments

As William Blake put it in Auguries of Innocence, written in 1803 but not published until 1863, “A Robin Redbreast in a cage, puts all heaven in a rage”. So did the ill-crafted concept of plausibility with the case law of the EPO’s Technical Boards of Appeal (TBA). It introduced an artificial cage that trapped…

CJEU, Patents, Unitary Patent, UPC

(Clifford Chance)/ /3 Comments

As readers will be well aware, one of the preferred hobbies of the Court of Justice of the European Union (“CJEU”) is to issue controversial judgments in intellectual property matters which, quite often, instead of providing guidance to national courts, raise more questions than they answer. After the Christmas break, the CJEU seems to have…

Patents, Unitary Patent, UPC

(Clifford Chance)/ /14 Comments

When the Unified Patent Court (“UPC”) endeavour was in the process of being designed back in the day, its architects presented the project as an example of a one-in-a-kind cosmopolitan litigation forum, the seat of patent judges and litigators from all cultures, skills, backgrounds, languages and walks of life. A cosmopolitan court that would set…

Damages, Patents, Spain

(Clifford Chance)/

On 23 June 2023, the Madrid Appeal Court (Section 32) published one of the most interesting judgments coming from Spanish courts during the last few years. The first point of interest is that this is one of the first judgments handed down by the brand new “Section 32” of the Madrid Appeal Court, recently established…

Spain, UPC

(Clifford Chance)/ /14 Comments

As explained in our entry UPC: four reasons why the PPA is not legally in force, published on April 21, 2022, one of the collateral damages of Brexit is that the conditions for the entry into force of the “Protocol to the Agreement on a UPC on Provisional Application” (the “PPA”), which included the ratification…

Patents, SPC

(Clifford Chance)/ /3 Comments

When the European Commission earlier today published the legislative proposals aimed at introducing a unitary SPC to be examined by a central examination procedure, one of the Beatle’s most beautiful songs immediately sprang to mind: The Long and Winding Road. In particular, the European Commission has published several legislative proposals, four of which are relevant…

Patents, Unitary Patent, UPC

(Clifford Chance)/ /1 Comment

As most readers will be well aware, Brexit has raised some fundamental issues for the Unified Patent Court (“UPC”) project, among which two points stand out. First, that, contrary to what it is envisaged in by Article 7.2 of the Agreement on a Unified Patent Court (“UPCA”), London will no longer be able to accommodate…

EPC, EPO, Patents

(Clifford Chance)/ /5 Comments

Christmas is a season for rest, family gatherings, warm wishes, hopes and good cheer. These days, children and adults alike may be preparing their wish list for Father Christmas. One of the gifts that patent aficionados are expecting with excitement for 2023 is a clear answer to the questions referred to the EPO Enlarged Board…